|
1
|
Jones MK and Oliver JD: Vibrio vulnificus:
Disease and pathogenesis. Infect Immun. 77:1723–1733. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu J, Yamane H and Paul WE:
Differentiation of effector CD4 T cell populations (*). Annu Rev
Immunol. 28:445–489. 2010. View Article : Google Scholar
|
|
3
|
Hickman SP, Chan J and Salgame P:
Mycobacterium tuberculosis induces differential cytokine production
from dendritic cells and macrophages with divergent effects on
naive T cell polarization. J Immunol. 168:4636–4642. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Linehan JL, Dileepan T, Kashem SW, Kaplan
DH, Cleary P and Jenkins MK: Generation of Th17 cells in response
to intranasal infection requires TGF-β1 from dendritic cells and
IL-6 from CD301b+ dendritic cells. Proc Natl Acad Sci
USA. 112:12782–12787. 2015. View Article : Google Scholar
|
|
5
|
Kapsenberg ML: Dendritic-cell control of
pathogen-driven T-cell polarization. Nat Rev Immunol. 3:984–993.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mizuno Y, Takada H, Nomura A, Jin CH,
Hattori H, Ihara K, Aoki T, Eguchi K and Hara T: Th1 and
Th1-inducing cytokines in Salmonella infection. Clin Exp Immunol.
131:111–117. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iwakura Y, Nakae S, Saijo S and Ishigame
H: The roles of IL-17A in inflammatory immune responses and host
defense against pathogens. Immunol Rev. 226:57–79. 2008. View Article : Google Scholar
|
|
8
|
Kolls JK and Khader SA: The role of Th17
cytokines in primary mucosal immunity. Cytokine Growth Factor Rev.
21:443–448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Atarashi K, Tanoue T, Ando M, Kamada N,
Nagano Y, Narushima S, Suda W, Imaoka A, Setoyama H, Nagamori T, et
al: Th17 cell induction by adhesion of microbes to intestinal
epithelial cells. Cell. 163:367–380. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li L, Shi QG, Lin F, Liang YG, Sun LJ, Mu
JS, Wang YG, Su HB, Xu B, Ji CC, et al: Cytokine IL-6 is required
in Citrobacter rodentium infection-induced intestinal Th17
responses and promotes IL-22 expression in inflammatory bowel
disease. Mol Med Rep. 9:831–836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa
SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, et al:
Interleukin-22 mediates early host defense against attaching and
effacing bacterial pathogens. Nat Med. 14:282–289. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Codolo G, Amedei A, Steere AC, Papinutto
E, Cappon A, Polenghi A, Benagiano M, Paccani SR, Sambri V, Del
Prete G, et al: Borrelia burgdorferi NapA-driven Th17 cell
inflammation in lyme arthritis. Arthritis Rheum. 58:3609–3617.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi Y, Liu XF, Zhuang Y, Zhang JY, Liu T,
Yin Z, Wu C, Mao XH, Jia KR, Wang FJ, et al: Helicobacter
pylori-induced Th17 responses modulate Th1 cell responses, benefit
bacterial growth, and contribute to pathology in mice. J Immunol.
184:5121–5129. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zelante T, De Luca A, Bonifazi P,
Montagnoli C, Bozza S, Moretti S, Belladonna ML, Vacca C, Conte C,
Mosci P, et al: IL-23 and the Th17 pathway promote inflammation and
impair anti-fungal immune resistance. Eur J Immunol. 37:2695–2706.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cohen J: The immunopathogenesis of sepsis.
Nature. 420:885–891. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Flierl MA, Rittirsch D, Gao H, Hoesel LM,
Nadeau BA, Day DE, Zetoune FS, Sarma JV, Huber-Lang MS, Ferrara JL,
et al: Adverse functions of IL-17A in experimental sepsis. FASEB J.
22:2198–2205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park JH, Cho YJ, Chun J, Seok YJ, Lee JK,
Kim KS, Lee KH, Park SJ and Choi SH: Complete genome sequence of
Vibrio vulnificus MO6-24/O. J Bacteriol. 193:2062–2063. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wright AC, Simpson LM, Oliver JD and
Morris JG Jr: Phenotypic evaluation of acapsular transposon mutants
of Vibrio vulnificus. Infect Immun. 58:1769–1773. 1990.PubMed/NCBI
|
|
19
|
Inaba K, Inaba M, Romani N, Aya H, Deguchi
M, Ikehara S, Muramatsu S and Steinman RM: Generation of large
numbers of dendritic cells from mouse bone marrow cultures
supplemented with granulocyte/macrophage colony-stimulating factor.
J Exp Med. 176:1693–1702. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Toma C, Higa N, Koizumi Y, Nakasone N,
Ogura Y, McCoy AJ, Franchi L, Uematsu S, Sagara J, Taniguchi S, et
al: Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins
and TLR/nucleotide-binding oligomerization domain-mediated NF-kappa
B signaling. J Immunol. 184:5287–5297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chuang CC, Chuang YC, Chang WT, Chen CC,
Hor LI, Huang AM, Choi PC, Wang CY, Tseng PC and Lin CF: Macrophage
migration inhibitory factor regulates interleukin-6 production by
facilitating nuclear factor-kappa B activation during Vibrio
vulnificus infection. BMC Immunol. 11:502010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee BC, Lee JH, Kim MW, Kim BS, Oh MH, Kim
KS, Kim TS and Choi SH: Vibrio vulnificus rtxE is important for
virulence, and its expression is induced by exposure to host cells.
Infect Immun. 76:1509–1517. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weigmann B, Tubbe I, Seidel D, Nicolaev A,
Becker C and Neurath MF: Isolation and subsequent analysis of
murine lamina propria mononuclear cells from colonic tissue. Nat
Protoc. 2:2307–2311. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Diehl S, Anguita J, Hoffmeyer A, Zapton T,
Ihle JN, Fikrig E and Rincón M: Inhibition of Th1 differentiation
by IL-6 is mediated by SOCS1. Immunity. 13:805–815. 2000.
View Article : Google Scholar
|
|
25
|
Jin W and Dong C: IL-17 cytokines in
immunity and inflammation. Emerg Microbes Infect. 2:e602013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu HP, Shih CC, Chu CM, Huang CY, Hua CC,
Liu YC and Chuang DY: Effect of interleukin-17 on in vitro cytokine
production in healthy controls and patients with severe sepsis. J
Formos Med Assoc. 114:1250–1257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chatterjee D and Chaudhuri K: Vibrio
cholerae O395 outer membrane vesicles modulate intestinal
epithelial cells in a NOD1 protein-dependent manner and induce
dendritic cell-mediated Th2/Th17 cell responses. J Biol Chem.
288:4299–4309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dey AK, Bhagat A and Chowdhury R: Host
cell contact induces expression of virulence factors and VieA, a
cyclic di-GMP phosphodiesterase, in Vibrio cholerae. J Bacteriol.
195:2004–2010. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim SM, Park JH, Lee HS, Kim WB, Ryu JM,
Han HJ and Choi SH: LuxR homologue SmcR is essential for Vibrio
vulnificus pathogenesis and biofilm detachment, and its expression
is induced by host cells. Infect Immun. 81:3721–3730. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lim JG, Choi SH and Camilli A: IscR is a
global regulator essential for pathogenesis of Vibrio vulnificus
and induced by host cells. Infect Immun. 82:569–578. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Oh MH, Jeong HG and Choi SH: Proteomic
identification and characterization of Vibrio vulnificus proteins
induced upon exposure to INT-407 intestinal epithelial cells. J
Microbiol Biotechnol. 18:968–974. 2008.PubMed/NCBI
|
|
32
|
Goo SY, Han YS, Kim WH, Lee KH and Park
SJ: Vibrio vulnificus IlpA-induced cytokine production is mediated
by Toll-like receptor 2. J Biol Chem. 282:27647–27658. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee SE, Kim SY, Jeong BC, Kim YR, Bae SJ,
Ahn OS, Lee JJ, Song HC, Kim JM, Choy HE, et al: A bacterial
flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant
activity to induce protective immunity. Infect Immun. 74:694–702.
2006. View Article : Google Scholar :
|
